# Paul Schulz, M.D. – FDA Inspection, Jul 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/paul-schulz-md/701d1a8e-9863-4ed7-abae-fbbd380a3eaa
Source feed: FDA_Inspections

> FDA inspection 1276292 of Paul Schulz, M.D., July 22, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276292
- Company Name: Paul Schulz, M.D.
- Inspection Date: 2025-07-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 3

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)

Company: https://www.keypedia.com/companies/paul-schulz-md/9385b561-5e91-41ad-abbc-f954ae6f436c

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
